The blood cancer, breast cancer, colon cancer, lung cancer, neuroblastoma, oral cancer, skin cancer, stomach cancer, thyroid cancer, ovarian cancer and pancreatic cancer showed insignificant associations with the IL-6 -174G/C polymorphism (Table 2). This evidence concerns the gene IL6 and hematopoietic and lymphoid system neoplasm.